Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

May 06, 2020 10:00 AM - May 07, 2020 4:45 PM

(Eastern Standard Time)

Fort Washington, PA 19034

Medical Affairs and Scientific Communications Forum

A Whole New World: Real World Evidence (RWE)

Session Chair(s)

Donna  Booth, PharmD

Donna Booth, PharmD

Head, Field Medical Accounts-East, US Medical Affairs

GlaxoSmithKline, United States

RWE plays an increasing role in healthcare decisions. Medical Information Departments vary in their understanding and approach to the dissemination for RWE based on guidance documents issued by FDA. As the US healthcare system continues to seek value for patients, it is increasingly important to have strategies for incorporating RWE into materials provided across the continuum of decision-makers (Regulators, Payers, Providers, and Patients). *Note: Audience participation will enhance the learning experience from this session.

Learning Objective :

At the conclusion of this session, participants should be able to:

  • Recognize the importance of RWE to the decision-making process
  • Discuss the FDA guidance documents that regulate the dissemination of RWE
  • Propose strategies for dissemination of RWE by sharing examples utilized by various Medical Information Departments that demonstrated success as well as areas for improvement

Speaker(s)

Donna  Booth, PharmD

Collaborative Discussion on the Use of RWE based on Recent FDA Guidance

Donna Booth, PharmD

GlaxoSmithKline, United States

Head, Field Medical Accounts-East, US Medical Affairs

Ellen  Whipple, PharmD

Collaborative Discussion on the Use of RWE based on Recent FDA Guidance

Ellen Whipple, PharmD

EW Associates, LLC, United States

Owner/Principal Writer

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.